Peptide record

TPDB45731

Antiviral standard
41 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45731
Antiviral
Anti-infective peptides
DRAVP 2.0 Peptipedia
standard
No
A 41-aa standard-residue antiviral peptide sequence curated from DRAVP 2.0 and Peptipedia, with an available 3D structural model.
Sequence
SVALVPHVGMGLETRTETWMSSEGAWKHVQRIETWILRHPG
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C209H325N61O58S2
NDCFY
EGTV
4684.37
8.06
7
4
16
+0
1.41
-0.307
80.73
Mammalian: 1.9 hour Yeast: >20 hour E.coli: >10 hour
16500
3.52
8
Residue Composition
number
2
A
3
R
0
N
0
D
0
C
4
E
1
Q
4
G
3
H
2
I
3
L
1
K
2
M
0
F
2
P
3
S
4
T
3
W
0
Y
4
V
Amino Acid Distribution
A: 2 R: 3 N: 0 D: 0 C: 0 E: 4 Q: 1 G: 4 H: 3 I: 2 L: 3 K: 1 M: 2 F: 0 P: 2 S: 3 T: 4 W: 3 Y: 0 V: 4
Chemical Descriptors
41 reviewed residue count
C209H325N61O58S2 sequence-only estimate (linear, free termini)
4684.37 sequence-only estimate (linear, free termini)
8.06 sequence-only estimate (linear, free termini)
+0 sequence-only estimate (linear, free termini)
1.41 sequence-only estimate (linear, free termini)
-0.307 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0